Structural basis for the dsRNA specificity of the Lassa virus NP exonucleaseLassa fever in post-conflict sierra leoneMultiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreakStructural basis for differential neutralization of ebolavirusesNeutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against itEbolavirus glycoprotein structure and mechanism of entryCrystal structure of a neutralizing human IGG against HIV-1: a template for vaccine designRecurring conformation of the human immunodeficiency virus type 1 gp120 V3 loopEbolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppressionComplex of a Protective Antibody with Its Ebola Virus GP Peptide Epitope: Unusual Features of a Vλx Light ChainStructure of the Ebola virus glycoprotein bound to an antibody from a human survivorTechniques and tactics used in determining the structure of the trimericebolavirusglycoproteinStructure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppressionMarburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon AntagonismCrystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA bindingA shared structural solution for neutralizing ebolavirusesStructure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola VirusThe Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal FoldEbolavirus VP35 Coats the Backbone of Double-Stranded RNA for Interferon AntagonismStructural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life CycleCrystal Structure of the Nipah Virus Phosphoprotein Tetramerization DomainCrystal Structure of Marburg Virus VP24Structural insights into RNA encapsidation and helical assembly of the Toscana virus nucleoproteinStructure of theReston ebolavirusVP30 C-terminal domainStructure of the LCMV nucleoprotein provides a template for understanding arenavirus replication and immunosuppressionHost-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing AntibodiesFine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunitsDevelopment of Prototype Filovirus Recombinant Antigen ImmunoassaysCathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change.Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNAEbola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusionHiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses.A model for neutralization of viruses based on antibody coating of the virion surface.The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.A "Trojan horse" bispecific-antibody strategy for broad protection against ebolavirusesEbola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.An update on the use of antibodies against the filoviruses.Structures of protective antibodies reveal sites of vulnerability on Ebola virus.
P50
Q21134064-59C872C3-4423-47A7-A368-BDA4C16FF83AQ24290732-A787BC56-3E75-455E-8781-BBE6745CE3E3Q24701722-50565ECE-2D74-4D53-9A00-B58E627BB311Q27014910-D5350ACB-26D5-4AF1-9EAB-59E292286E07Q27489891-CE0EB846-3213-4550-BE0C-7675A209008CQ27490991-2F47C8B8-8B7C-4721-8F52-A81B4B64B71BQ27634018-A0A19B84-DD03-4406-AAD6-0F5C16295959Q27642457-828388CC-0B45-4E30-997E-FCEFD60D81CCQ27646608-0C73F887-2FFE-41D2-A008-9A191D49E611Q27649064-F0AAC580-5A62-49DE-821C-082D63408D63Q27651112-D7EC7659-17F0-4B85-9D39-E54741105FBEQ27658238-E27C57F5-2458-4D73-AB15-69B53724320FQ27666703-2AC297AD-743E-4910-869C-40B4EDFC6A7BQ27673907-D6BDC1F7-05CB-4224-B922-A803F4086B1EQ27675573-C65B9976-A3EA-44A6-8BD7-242AFF09E477Q27675675-B1710454-CB54-41B1-9A8F-78B4200B084BQ27676230-C9342ED9-891F-420E-BC5F-BA4F9941C9B8Q27677595-8BE2CFB6-CDEE-4EB4-AFF2-21811ED62917Q27678917-8DF84B1E-AA8F-4C7D-B14F-8280551BF05CQ27679704-755DCB95-1A45-47D7-8D3F-F691D3F33417Q27680451-DDD202DC-0CD4-4130-9026-A22A76CCA873Q27681924-C572532D-BFF9-415B-B337-3F290144842FQ27682730-77A3D6FD-272F-480B-BB73-46CA5F4FFBE9Q27682908-6A6957D4-46A6-4096-BF27-5D41596AEF6BQ27684274-FD182FD8-03AB-45AB-8979-5810C684801EQ27704173-69F73804-378F-4B3C-A649-D651EAAE8317Q28217208-336CC651-58C8-4221-97C3-41BCEEDC61F6Q28602816-C1B8A862-F75C-4810-9D38-9F6F33B918E5Q28607807-C80412EF-E20B-4589-9AC1-2CBE34E6C607Q30426228-6167F316-23B9-4B1A-82F4-A3831EB0F1EDQ31016954-11F7B182-DA60-4361-82A4-667AC493EEA3Q33568288-E0637CDA-2D6D-4C1C-B3C9-1CE12E8B3DD2Q34079366-9D5F4C87-7C6F-40DF-A502-1D5B73AD573FQ34266468-FC9BE970-A43E-4FE2-A70A-0E24A8A90C33Q34302544-5AFFCDDE-D0FE-46B7-ADBF-73DC54906EAEQ34342352-CC533FCC-7022-4C1D-980C-529F6CFE24E3Q34539842-1700FE12-7DAC-4AA7-9E43-3D0604E751ABQ34648134-A9C6032A-BFEC-439F-908B-72DDAA5E6B11Q34657170-C10FC5C6-38D8-4DFF-B9C6-73FAE2830FF2Q34661120-24008FF2-B0D9-45C1-B50B-6DEEAEADDAFA
P50
description
American structural biologist, immunologist and researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Erica Ollmann Saphire
@ast
Erica Ollmann Saphire
@en
Erica Ollmann Saphire
@es
Erica Ollmann Saphire
@nl
Erica Ollmann Saphire
@sl
type
label
Erica Ollmann Saphire
@ast
Erica Ollmann Saphire
@en
Erica Ollmann Saphire
@es
Erica Ollmann Saphire
@nl
Erica Ollmann Saphire
@sl
altLabel
E O Saphire
@en
E Saphire
@en
E. O. Saphire
@en
E. Saphire
@en
Erica O Saphire
@en
Erica O. Saphire
@en
Saphire E
@en
Saphire E. O.
@en
Saphire E.
@en
Saphire EO
@en
prefLabel
Erica Ollmann Saphire
@ast
Erica Ollmann Saphire
@en
Erica Ollmann Saphire
@es
Erica Ollmann Saphire
@nl
Erica Ollmann Saphire
@sl
P214
P244
P108
P1153
6602956688
P21
P214
P244
n2014180037
P31
P496
0000-0002-1206-7451
P735
P7859
lccn-n2014180037